- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/85 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
Patent holdings for IPC class C07D 307/85
Total number of patents in this class: 157
10-year publication summary
|
16
|
10
|
8
|
13
|
11
|
5
|
17
|
10
|
15
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Enyo Pharma | 53 |
9 |
| Pharmacyclics LLC | 242 |
8 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3019 |
6 |
| Cancer Research Technology Limited | 516 |
5 |
| Isosterix, Inc. | 8 |
5 |
| Merck Patent GmbH | 5755 |
4 |
| Bayer AG | 3563 |
4 |
| Sunshine Lake Pharma Co., Ltd. | 631 |
4 |
| Calico Life Sciences LLC | 120 |
4 |
| F. Hoffmann-La Roche AG | 7792 |
3 |
| The Broad Institute, Inc. | 1992 |
3 |
| Symed Labs Limited | 50 |
3 |
| University of Kansas | 928 |
3 |
| Vanderbilt University | 2033 |
3 |
| Nido Biosciences, Inc. | 16 |
3 |
| Novartis AG | 10172 |
2 |
| Boehringer Ingelheim Vetmedica GmbH | 1274 |
2 |
| Janssen Pharmaceutica N.V. | 3142 |
2 |
| Pfizer Inc. | 3422 |
2 |
| Bionomics Limited | 85 |
2 |
| Other owners | 80 |